Cytomegalovirus and the role of interferon in the expression of tumor necrosis factor-related apoptosis-inducing ligand in the placenta

American Journal of Obstetrics and Gynecology

Volumn 197, Issue 6, 2007, Pages 608.e1-608.e6

  Andrews, Janet I ^a   Griffith, Thomas S ^a   Meier, Jeffery L ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

cytomegalovirus; interferon; placenta; tumor necrosis factor related apoptosis inducing ligand

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; INTERFERON; MESSENGER RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNITY; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 36448939460     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.04.031     Document Type: Article

References (30)

1. Stagno S., Pass R.F., Dworsky M.E., and Alford Jr. C.A. Maternal cytomegalovirus infection and perinatal transmission. Clin Obstet Gynecol 25 (1982) 563-576
2. Fowler K.B., McCollister F.P., Dahle A.J., Boppana S., Britt W.J., and Pass R.F. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr 130 (1997) 624-630
3. Plotkin S.A. Congenital cytomegalovirus infection and its prevention. Clin Infect Dis 38 (2004) 1038-1039
4. Hayes K., and Gibas H. Placental cytomegalovirus infection without fetal involvement following primary infection in pregnancy. J Pediatr 79 (1971) 401-405
5. Sinzger C., Muntefering H., Loning T., Stoss H., Plachter B., and Jahn G. Cell types infected in human cytomegalovirus placentitis identified by immunohistochemical double staining. Virchows Arch A Pathol Anat Histopathol 423 (1993) 249-256
6. McDonagh S., Maidji E., Chang H.T., and Pereira L. Patterns of human cytomegalovirus infection in term placentas: a preliminary analysis. J Clin Virol 35 (2006) 210-215
7. Fortunato E.A., McElroy A.K., Sanchez I., and Spector D.H. Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus. Trends Microbiol 8 (2000) 111-119
8. Zhu H., Cong J.P., Mamtora G., Gingeras T., and Shenk T. Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc Natl Acad Sci U S A 95 (1998) 14470-14475
9. Raftery M.J., Schwab M., Eibert S.M., Samstag Y., Walczak H., and Schonrich G. Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. Immunity 15 (2001) 997-1009
10. Miura Y., Misawa N., Maeda N., et al. Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice. J Exp Med 193 (2001) 651-660
11. Sedger L.M., Shows D.M., Blanton R.A., et al. IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. J Immunol 163 (1999) 920-926
12. Preston C.M., Harman A.N., and Nicholl M.J. Activation of interferon response factor-3 in human cells infected with herpes simplex virus type 1 or human cytomegalovirus. J Virol 5 (2001) 8909-8916
13. Fant M.E. In vitro growth rate of placental fibroblasts is developmentally regulated. J Clin Invest 88 (1991) 1697-1702
14. Rodriguez J.E., Loepfe T.R., and Swack N.S. Beta interferon production in primed and unprimed cells infected with human cytomegalovirus. Arch Virol 94 (1987) 177-189
15. Meier J.L., and Stinski M.F. Effect of a modulator deletion on transcription of the human cytomegalovirus major immediate-early genes in infected undifferentiated and differentiated cells. J Virol 71 (1997) 1246-1255
16. Meier J.L., Keller M.J., and McCoy J.J. Requirement of multiple cis-acting elements in the human cytomegalovirus major immediate-early distal enhancer for viral gene expression and replication. J Virol 76 (2002) 313-326
17. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
18. Boehme K.W., Singh J., Perry S.T., and Compton T. Human cytomegalovirus elicits a coordinated cellular antiviral response via envelope glycoprotein B. J Virol 78 (2004) 1202-1211
19. Kayagaki N., Yamaguchi N., Nakayama M., Eto H., Okumura K., and Yagita H. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I IFNs. J Exp Med 189 (1999) 1451-1460
20. Goodbourn S., Didcock L., and Randall R.E. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 81 (2000) 2341-2364
21. Boehrer S., Nowak D., Hoelzer D., Mitrou P.S., and Chow K.U. The molecular biology of TRAIL-mediated signaling and its potential therapeutic exploitation in hematopoietic malignancies. Curr Med Chem 13 (2006) 2091-2100
22. Kowalik T.F., Wing B., Haskill J.S., Azizkhan J.C., Baldwin Jr. A.S., and Huang E.S. Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection. Proc Natl Acad Sci U S A 90 (1993) 1107-1111
23. Lee G.C., Yi H.A., and Lee C.H. Stimulation of interferon-beta gene expression by human cytomegalovirus via nuclear factor kappa B and phosphatidylinositol 3-kinase pathway. Virus Res 117 (2006) 209-214
24. Yurochko A.D., Kowalik T.F., Huong S.M., and Huang E.S. Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J Virol 69 (1995) 5391-5400
25. Jarvis M.A., Borton J.A., Keech A.M., et al. Human cytomegalovirus attenuates interleukin-1beta and tumor necrosis factor alpha proinflammatory signaling by inhibition of NF-kappaB activation. J Virol 80 (2006) 5588-5598
26. Baetu T.M., Kwon H., Sharma S., Grandvaux N., and Hiscott J. Disruption of NF-kappaB signaling reveals a novel role for NF-kappaB in the regulation of TNF-related apoptosis-inducing ligand expression. J Immunol 167 (2001) 3164-3173
27. Abate D.A., Watanabe S., and Mocarski E.S. Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J Virol 78 (2004) 10995-11006
28. DeFilippis V.R., Robinson B., Keck T.M., Hansen S.G., Nelson J.A., and Fruh K.J. Interferon regulatory factor 3 is necessary for induction of antiviral genes during human cytomegalovirus infection. J Virol 80 (2006) 1032-1037
29. Kirshner J.R., Karpova A.Y., Kops M., and Howley P.M. Identification of TRAIL as an interferon regulatory factor 3 transcriptional target. J Virol 79 (2005) 9320-9324
30. Chen L., Liu X., Zhu Y., Cao Y., Sun L., and Jin B. Localization and variation of TRAIL and its receptors in human placenta during gestation. Life Sci 74 (2004) 1479-1486